34 Phase 2 study of neoadjuvant docetaxel and androgen suppression (AS) Plus Radiation Therapy (RT) for high risk localized prostate cancer (HRLCaP)
Saved in:
| Title: | 34 Phase 2 study of neoadjuvant docetaxel and androgen suppression (AS) Plus Radiation Therapy (RT) for high risk localized prostate cancer (HRLCaP) |
|---|---|
| Authors: | McKenzie, M., Chi, K., Neville, A., Ellard, S., Baerg, B., Ruether, D., Winquist, E., Segal, R., Attwell, A., Lukka, H. |
| Source: | Radiotherapy & Oncology. Sep2006, Vol. 80, pS10-S11. 0p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
